Vaccines targeting the neovasculature of tumors

Main Article Content

Agata Matejuk Qixin Leng Szu-Ting Chou Archibald J Mixson

Abstract

 

Angiogenesis has a critical role in physiologic and disease processes. For the growth of tumors, angiogenesis must occur to carry sufficient nutrients to the tumor. In addition to growth, development of new blood vessels is necessary for invasion and metastases of the tumor. A number of strategies have been developed to inhibit tumor angiogenesis and further understanding of the interplay between tumors and angiogenesis should allow new approaches and advances in angiogenic therapy. One such promising angiogenic approach is to target and inhibit angiogenesis with vaccines. This review will discuss recent advances and future prospects in vaccines targeting aberrant angiogenesis of tumors. The strategies utilized by investigators have included whole endothelial cell vaccines as well as vaccines with defined targets on endothelial cells and pericytes of the developing tumor endothelium. To date, several promising anti-angiogenic vaccine strategies have demonstrated marked inhibition of tumor growth in pre-clinical trials with some showing no observed interference with physiologic angiogenic processes such as wound healing and fertility.

Article Details

How to Cite
MATEJUK, Agata et al. Vaccines targeting the neovasculature of tumors. Vascular Cell, [S.l.], v. 3, n. 1, p. 7, mar. 2011. ISSN 2045-824X. Available at: <https://vascularcell.com/index.php/vc/article/view/10.1186-2045-824X-3-7>. Date accessed: 23 oct. 2021. doi: http://dx.doi.org/10.1186/2045-824X-3-7.
Section
Review